Officials generally describe three camps inside the administration on the hydroxychloroquine debate: One group of Trump devotees, like Navarro and other policy advisers and outside allies, who fully support the president’s belief that the drugs represent a viable path to rapidly controlling the outbreak…

Meanwhile, officials in a second group, such as Surgeon General Jerome Adams and Food and Drug Administration Commissioner Stephen Hahn, are willing to entertain the possibility that the drugs work — given the lack of other existing treatments — but stress that the decision should be made between a doctor and a patient…

Finally, a third group of officials — like Fauci — have repeatedly taken a tougher line against widespread use of the drugs, urging the president to wait on what clinical trials will reveal. Officials also have grown concerned about the president’s advocacy of combining hydroxychloroquine and zithromax, a treatment that some front-line providers have attempted but could significantly raise the risk of cardiac problems.